Highlight Report: Import of Fatty Acids by Metastasizing Tumor Cells
  Overview
        
                  
          
  Authors
          Authors
  Affiliations
        Affiliations
    Soon will be listed here.
  
  References
                              1.
  
    Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H
    
    . The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008; 68(13):5405-13.
    
          DOI: 10.1158/0008-5472.CAN-07-5206.
    
    View
  
2.
  
    Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B
    
    . Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res. 2010; 12(3):R44.
          PMC: 2917039.
    
          DOI: 10.1186/bcr2599.
    
    View
  
3.
  
    Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z
    
    . A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res. 2012; 18(9):2695-703.
    
          DOI: 10.1158/1078-0432.CCR-11-2210.
    
    View
  
4.
  
    Stewart J, Marchan R, Lesjak M, Lambert J, Hergenroeder R, Ellis J
    
    . Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis. Proc Natl Acad Sci U S A. 2012; 109(21):8155-60.
          PMC: 3361409.
    
          DOI: 10.1073/pnas.1117654109.
    
    View
  
5.
  
    Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R
    
    . Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer. 2012; 21(4):491-9.
    
          DOI: 10.1007/s12282-012-0404-8.
    
    View